Compounds > mdl 62873
Page last updated: 2024-10-15

mdl 62873

Cross-References

ID SourceID
PubMed CID16132175
MeSH IDM0186260

Synonyms (15)

Synonym
teichoplanin a2-carboxyamide derivative
ristomycin a aglycone, 34-o-(2-(acetylamino)-2-deoxy-beta-d-glucopyranosyl)-22,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-o-(2-deoxy-2-((8-methyl-1-oxononyl)amino)-beta-d-glucopyranosyl)-38-(((3-(dimethylamino)propyl)amino)carbonyl)-42-o-al
mideplanin
mdl-62873
unii-q0m2emf621
mdl 62873
carboxyamido-teicoplanin a2
mdl-62211
mdl 62211
122173-74-4
gtpl10830
cta a1
mdl62873
Q27286855
AKOS040747165
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
ciprofloxacin
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.. ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.		1.9810aminoquinoline;
cyclopropanes;
fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone;
zwitterion		antibacterial drug;
antiinfective agent;
antimicrobial agent;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
environmental contaminant;
topoisomerase IV inhibitor;
xenobiotic
vancomycin
Vancomycin: Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.. vancomycin : A complex glycopeptide from Streptomyces orientalis. It inhibits a specific step in the synthesis of the peptidoglycan layer in the Gram-positive bacteria Staphylococcus aureus and Clostridium difficile.		3.2360glycopeptideantibacterial drug;
antimicrobial agent;
bacterial metabolite
rifamycins
[no description available]		1.9710
ristocetin
Ristocetin: An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro.. ristocetin : A heterodetic cyclic peptide that is produced by species of Amycolatopsis and Nocardia.		3.4880glycopeptide;
heterodetic cyclic peptide;
macrocycle;
tetrasaccharide derivative		antibacterial drug;
antimicrobial agent;
bacterial metabolite;
platelet-activating factor receptor agonist
daptomycin
[no description available]		6.9710
chloroorienticin a
chloroorienticin A: structure given in first source; isolated from Amycolatopsis orientalis		1.9810
teicoplanin aglycone
teicoplanin aglycone: structure given in first source		1.9710
ConditionIndicatedRelationship StrengthStudiesTrials
Bacteremia
The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.		01.9810
Blood Poisoning
[description not available]		01.9810
Bacterial Disease
[description not available]		01.9810
Bacterial Endocarditides
[description not available]		01.9810
Bacterial Infections
Infections by bacteria, general or unspecified.		01.9810
Endocarditis, Bacterial
Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use.		01.9810
Sepsis
Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.		01.9810